Matthew Brams
Fortuna: 33 933 $ al 31/05/2026
Fortuna: 33 933 $ al 31/05/2026
Matthew N.
Brams is the founder of Cingulate, Inc., founded in 2012, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is the founder of Cingulate Works, Inc., founded in 2013, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is also the founder of Cingulate Therapeutics LLC..
Dr. Brams currently works at Baylor College of Medicine as a Clinical Associate Professor.
Formerly, Dr. Brams was Medical Director & Principal at Bayou City Research, Inc. from 1999 to 2021.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from The University of Texas Health Science Center at Houston.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CINGULATE, INC. 0,06 % | 18/05/2026 | 8.157 ( 0,06 % ) | 33 933 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CINGULATE INC. | Fundador | 01/05/2012 |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Fundador | - |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Fundador | 01/01/2013 |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Bayou City Research, Inc. | Director Técnico/Científico/I+D | 01/01/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bayou City Research, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.